Home> Products> require activation

{ "products": [ { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5092283075a19d4f2db6bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cyclosporine Eye Drops 0.05% w/v", "description": "Cyclosporine eye drops 0.05% are a prescription ophthalmic emulsion used to treat chronic dry eye disease (keratoconjunctivitis sicca) caused by ocular surface inflammation. Unlike lubricating tear substitutes that only manage symptoms, cyclosporine works as a calcineurin-inhibitor immunomodulator that calms the underlying inflammation suppressing your eyes' natural tear production. It is not a steroid. The standard dose is one drop in each affected eye, twice daily, about 12 hours apart, and visible improvement in tear production typically takes 6–12 weeks, with full benefit sometimes taking up to 3–6 months of consistent use. Common side effects include temporary burning, stinging, redness, and watery eyes at the time of instillation. It is a Schedule H prescription-only medicine in India and should be used only under a qualified ophthalmologist's guidance.\n\nWhat Is Cyclosporine Eye Drops 0.05%?\nCyclosporine eye drops 0.05% (ophthalmic emulsion) is a prescription formulation designed to manage chronic dry eye disease, a condition in which the eyes fail to produce enough tears or produce tears of poor quality, often because of an underlying inflammatory process on the ocular surface and in the lacrimal (tear-producing) gland.\nThis formulation is commonly prescribed for patients whose dry eye is presumed to be due to ocular inflammation — for example, those with moderate to severe dry eye, keratoconjunctivitis sicca, or dry eye associated with conditions like Sjögren's syndrome, that has not responded adequately to artificial tears alone.\nCyclosporine belongs to a class of drugs called calcineurin inhibitors. It differs fundamentally from corticosteroid eye drops, which suppress inflammation broadly and carry risks like raised intraocular pressure and cataract formation with long-term use. Cyclosporine instead selectively dampens the T-cell-mediated inflammatory response that is thought to suppress tear gland function, allowing the eye's own tear-producing mechanism to gradually recover.\n\nHow Do Cyclosporine Eye Drops Work? (Mechanism of Action)\n\nInflammation on the ocular surface – In chronic dry eye, T-lymphocytes infiltrate the conjunctiva and lacrimal gland, triggering a self-perpetuating inflammatory cycle.\nCalcineurin inhibition – Cyclosporine binds to a cellular protein (cyclophilin) and blocks calcineurin, an enzyme required to activate T-cells.\nReduced T-cell activation – With calcineurin blocked, T-cells cannot produce the inflammatory signals (such as interleukin-2) that damage the lacrimal gland and conjunctival tissue.\nRestoration of tear production – As local inflammation subsides over weeks to months, the lacrimal gland's ability to produce natural tears gradually improves.\nImproved tear film stability – With reduced inflammation and increased natural tear volume, patients typically notice less dryness, grittiness, and ocular surface damage over time.\n\nThis is why cyclosporine drops are described as disease-modifying for dry eye rather than purely symptomatic — they address a root inflammatory cause instead of simply lubricating the eye.\n\nClinical Indications\nIndicationDetailsChronic dry eye disease (keratoconjunctivitis sicca)Primary approved use; especially where tear production is suppressed due to ocular inflammationModerate to severe dry eye not controlled by artificial tearsSecond-line option when lubricants alone are insufficientDry eye associated with autoimmune conditionsE.g., Sjögren's syndrome-related dry eye, under specialist supervisionPost-refractive surgery dry eye (select cases)Sometimes used off-label under ophthalmologist guidance\n\nDosage & Administration\nParameterRecommendationStandard doseOne drop in each affected eye, twice dailyDosing intervalApproximately 12 hours apartContact lens useRemove lenses before instillation; wait at least 15 minutes before reinsertingOnset of noticeable effectUsually 6–12 weeksFull therapeutic benefitMay take up to 3–6 months of continuous useMissed doseContinue with next scheduled dose; do not double upDiscontinuationOnly under medical advice — symptoms may return if stopped prematurely\nNote: Cyclosporine eye drops are for long-term, continuous use as directed by your ophthalmologist. Improvement is gradual, not immediate, and consistent daily use is essential for benefit.\n\nKey Benefits\n\nTargets the underlying inflammatory cause of chronic dry eye rather than only masking symptoms\nCan increase natural tear production over sustained use\nGenerally well tolerated for long-term use, since it is not a steroid and does not carry steroid-related risks like elevated eye pressure or cataract with routine use\nMay reduce dependence on frequent artificial tear instillation over time\nSuitable for long-term maintenance therapy in chronic, relapsing dry eye disease\nCan improve comfort during visually demanding tasks (screen use, reading, driving) affected by chronic dryness\n\n\nPrecautions\n\nUse strictly as prescribed by an ophthalmologist; do not self-medicate\nNot intended for immediate relief of dry eye symptoms — artificial tears may be used concurrently for interim comfort as advised by your doctor\nShould not be used in the presence of an active ocular infection unless specifically directed by a physician\nInform your doctor if you are pregnant, breastfeeding, or have any known hypersensitivity to cyclosporine or emulsion components\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\nIf wearing contact lenses, remove before application and reinsert only after 15 minutes\nDo not use expired or previously opened single-use vials, if applicable to your product format\nRegular ophthalmic follow-up is recommended to monitor treatment response\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation upon instillation\nEye redness\nWatery eyes (excessive tearing)\nEye discomfort or a feeling of something in the eye\nTemporary blurred vision immediately after application\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nPersistent or worsening eye pain\nSigns of eye infection (discharge, significant redness, swelling)\nVisual disturbance that does not resolve\nSigns of an allergic reaction (eyelid swelling, itching, rash)\n\nIf any serious or persistent symptom occurs, discontinue use and consult your ophthalmologist immediately.\n\nComparison: Cyclosporine Eye Drops vs. Other Dry Eye Treatments\nTreatmentMechanismOnset of ActionLong-Term Use ProfileCyclosporine 0.05% dropsCalcineurin inhibitor; reduces inflammation, restores natural tear productionWeeks to monthsGenerally suitable for continuous long-term useArtificial tears / lubricantsSymptomatic lubrication onlyImmediate, short-livedSafe but does not address inflammation; frequent reapplication neededCorticosteroid eye dropsBroad anti-inflammatory actionFast (days)Not recommended for long-term use due to risk of raised IOP, cataractLifitegrast ophthalmic solutionLFA-1 antagonist; blocks a different inflammatory pathwayWeeksAlternative option, mechanism differs from cyclosporine\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported patients showing improved tear production at 6 months[Placeholder – insert verified clinical trial statistic]Prevalence of chronic dry eye disease in adults[Placeholder – insert epidemiological reference]Average time to symptomatic improvement[Placeholder – insert verified reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Cyclosporine Eye Drops 0.05%\nThe price of cyclosporine eye drops 0.05% varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nCyclosporine eye drops 0.05% represent a meaningful shift in how chronic dry eye disease is managed — moving beyond temporary lubrication to address the underlying inflammatory process that suppresses natural tear production. For patients with moderate to severe dry eye that hasn't responded well to artificial tears alone, this calcineurin-inhibitor therapy offers a disease-modifying option that, with consistent long-term use, can meaningfully improve ocular comfort and tear film health. Because benefits build gradually over weeks to months, patience and adherence to the prescribed twice-daily regimen are essential. As with any prescription ophthalmic therapy, cyclosporine eye drops should only be used under the guidance of a qualified ophthalmologist, who can confirm suitability, monitor progress, and adjust care as needed.\n\nFrequently Asked Questions\n\n1. What are cyclosporine 0.05% eye drops used for?\nCyclosporine 0.05% eye drops are used to treat chronic dry eye disease caused by ocular surface inflammation. They help increase natural tear production in patients whose tear glands are suppressed due to inflammation, particularly when artificial tears alone aren't enough.\n\n2. How long can I use cyclosporine eye drops?\nCyclosporine eye drops are typically used long-term, as chronic dry eye is an ongoing condition. Many patients continue therapy for months to years under regular ophthalmologist supervision, since symptoms can return if the medication is stopped.\n\n3. Is Cyclomune a steroid?\nNo. Cyclomune (a brand of cyclosporine ophthalmic emulsion) is not a steroid. It is a calcineurin-inhibitor immunomodulator that works differently from steroid eye drops and does not carry the same risk of raised eye pressure or cataract associated with long-term steroid use.\n4. How quickly do cyclosporine eye drops start working?\nMost patients begin noticing improvement in tear production and dry eye symptoms within 6 to 12 weeks, though full benefit may take up to 3 to 6 months of consistent, twice-daily use.\n\n5. Can cyclosporine damage eyes?\nWhen used exactly as prescribed, cyclosporine eye drops are generally considered safe for long-term use. Temporary burning, stinging, or watering can occur at the time of instillation, but serious eye damage is uncommon. Any persistent pain, vision changes, or signs of infection should be reported to your ophthalmologist promptly.\n\n6. How much are cyclosporine 0.05% eye drops?\nPricing varies by brand, pack size, and region. Since this is a prescription-only medicine, please check current pricing with your prescribing doctor or a licensed pharmacy.\n\n7. Is cyclosporine a steroid?\nNo. Cyclosporine is a calcineurin inhibitor, a category of immunomodulating medication that is pharmacologically distinct from corticosteroids (steroids), even though both can reduce inflammation.\n\n8. Can I wear contact lenses while using cyclosporine eye drops?\nContact lenses should be removed before applying the drops and can typically be reinserted after about 15 minutes, unless your ophthalmologist gives different instructions.\n9. What happens if I stop using cyclosporine eye drops suddenly?\nStopping suddenly may cause dry eye symptoms to gradually return, since the underlying inflammation is no longer being managed. Always consult your doctor before discontinuing treatment.\n\n10. Can cyclosporine eye drops be used with artificial tears?\nYes, in many cases artificial tears can be used alongside cyclosporine drops for additional comfort, especially during the initial weeks before cyclosporine's full effect develops. Confirm timing and spacing with your doctor.\n\n11. Who should not use cyclosporine eye drops?\nPatients with known hypersensitivity to cyclosporine or its components, active untreated eye infections, or specific contraindications identified by their doctor should not use this medication without medical clearance.\n\n12. Are cyclosporine eye drops safe during pregnancy?\nUse during pregnancy or breastfeeding should only occur under medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting treatment.\n\n13. What is the difference between cyclosporine eye drops and lubricating eye drops?\nLubricating (artificial tear) drops provide temporary symptomatic relief by adding moisture to the eye, while cyclosporine drops target the underlying inflammation responsible for reduced natural tear production, offering a longer-term, disease-modifying approach.\n\n14. Can children use cyclosporine eye drops?\nUse in children should only be under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n\n15. Do cyclosporine eye drops cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients. This usually resolves quickly. If blurred vision persists, consult your doctor.\n\n16. Can cyclosporine eye drops be used with other eye medications?\nOther eye medications, including other prescription drops, should only be combined with cyclosporine under your ophthalmologist's guidance, with appropriate spacing between different drops.\n\n17. Why do cyclosporine eye drops take so long to work?\nBecause cyclosporine works by gradually reducing chronic inflammation in the lacrimal gland and ocular surface rather than providing instant lubrication, visible improvement in natural tear production takes weeks to months rather than being immediate.", "price": 495.0, "discountamount": 149.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2468, "imageuri": "https://productimages.withfloats.com/actual/6a50922a464ced2a630398a1.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50922a464ced2a630398a1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T06:33:12.096Z", "updatedon": "2026-07-10T06:33:12.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cyclosporine-eye-drops-0-05-w-v/2468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION CYCLOPURE 0.5 mg", "category": "Opthalmology Range", "tags": [ "Cyclosporine Eye Drops 0.05% w/v", "cyclosporine eye drops", "cyclosporine eye drops uses", "cyclosporine eye drops ip 0.05 w/v", "cyclosporine eye drops price", "cyclosporine eye drops uses in hindi", "cyclosporine eye drops side effects", "cyclosporine eye drops 0.05", "cyclosporine eye drops brand name", "cyclosporine eye drops india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69662101a96bbf383231d700", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FABRICAL MG K₂7", "description": "FABRICAL MG K₂7 represents a scientifically advanced nutritional supplement that combines essential minerals and vitamins in a synergistic formulation designed to support optimal bone health, cardiovascular function, and overall metabolic wellness. This innovative product brings together six critical nutrients—Calcium Citrate Maleate, Magnesium Bisglycinate, Vitamin D3, Vitamin K2-7 (Menaquinone-7), Zinc, and Methylcobalamin—in precise therapeutic ratios that maximize bioavailability and clinical effectiveness.\nUnlike conventional calcium supplements that focus solely on calcium supplementation, FABRICAL MG K₂7 adopts a comprehensive, multi-nutrient approach that addresses the complex interplay between various micronutrients essential for skeletal integrity, neuromuscular function, immune competence, and metabolic regulation. This sophisticated formulation reflects current understanding of nutritional biochemistry, recognizing that optimal health outcomes require balanced supplementation rather than isolated nutrient provision.\nThe product has been meticulously formulated to address the growing epidemic of nutritional deficiencies affecting diverse populations, from elderly individuals experiencing age-related bone loss to young adults with suboptimal dietary intake, pregnant women with increased nutritional demands, and individuals with chronic conditions affecting nutrient absorption or utilization. FABRICAL MG K₂7 serves as a convenient, evidence-based solution for maintaining nutritional adequacy and supporting long-term health across various life stages.\nDetailed Understanding of FABRICAL MG K₂7 Components\nCalcium Citrate Maleate: Superior Calcium Bioavailability\nCalcium Citrate Maleate represents the premium form of calcium supplementation, offering significantly enhanced absorption compared to traditional calcium carbonate. This advanced calcium complex demonstrates approximately 25-30% better bioavailability, making it particularly valuable for individuals with reduced gastric acid production, including elderly populations and those taking proton pump inhibitors or H2-receptor antagonists. Unlike calcium carbonate, which requires acidic conditions for optimal dissolution, Calcium Citrate Maleate can be absorbed efficiently regardless of meal timing or stomach pH, providing greater flexibility and convenience.\nThe maleate component further enhances calcium absorption and utilization by supporting cellular energy metabolism and mitochondrial function. This sophisticated formulation ensures that supplemented calcium reaches target tissues—bones, teeth, muscles, and nerves—where it performs essential physiological functions rather than accumulating in soft tissues where it could potentially contribute to unwanted calcification.\nMagnesium Bisglycinate: The Gentle Magnesium Choice\nMagnesium Bisglycinate, also known as magnesium glycinate, stands as one of the most bioavailable and well-tolerated forms of magnesium supplementation. This chelated form, where magnesium is bound to two molecules of the amino acid glycine, offers exceptional absorption rates approaching 80-90% while minimizing the gastrointestinal side effects—particularly diarrhea—commonly associated with other magnesium forms like magnesium oxide or sulfate.\nMagnesium plays over 300 enzymatic roles throughout the body, making it indispensable for energy production, protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. Within FABRICAL MG K₂7, magnesium works synergistically with calcium, maintaining the critical calcium-magnesium balance essential for proper muscular contraction and relaxation, cardiovascular rhythm stability, and skeletal mineralization.\nVitamin D3: The Sunshine Vitamin in Its Active Form\nVitamin D3 (cholecalciferol) represents the most bioactive form of vitamin D, identical to what human skin synthesizes upon ultraviolet B exposure. This fat-soluble vitamin functions more accurately as a hormone, regulating calcium absorption from the intestines, maintaining serum calcium and phosphorus concentrations within optimal ranges, and modulating bone remodeling by both osteoblasts and osteoclasts.\nBeyond skeletal functions, Vitamin D3 exerts profound influences on immune system regulation, cellular differentiation and proliferation, neuromuscular function, and inflammation modulation. Vitamin D receptors exist throughout the body—in tissues ranging from the brain and heart to immune cells and muscle—highlighting its systemic importance. The inclusion of Vitamin D3 in FABRICAL MG K₂7 ensures that supplemented calcium can be effectively absorbed and utilized, preventing the futility of calcium supplementation in vitamin D-deficient states.\nVitamin K2-7: The Missing Link in Bone and Cardiovascular Health\nVitamin K2-7, specifically the menaquinone-7 (MK-7) form, represents perhaps the most revolutionary component of FABRICAL MG K₂7. This long-chain vitamin K2 demonstrates superior bioavailability and longer half-life compared to vitamin K1 (phylloquinone) found in green vegetables or shorter-chain K2 forms. Vitamin K2-7's critical function involves activating proteins responsible for proper calcium utilization—specifically matrix Gla protein (MGP) and osteocalcin.\nOsteocalcin, produced by bone-building osteoblasts, requires vitamin K2-dependent carboxylation to become active and effectively bind calcium into bone matrix, strengthening skeletal structure. Simultaneously, Vitamin K2-7 activates MGP, which prevents calcium deposition in arterial walls and soft tissues, directing calcium away from cardiovascular structures where it contributes to atherosclerosis and arterial stiffness. This dual action—promoting bone calcification while preventing vascular calcification—makes Vitamin K2-7 uniquely valuable, addressing the “calcium paradox” where individuals may simultaneously experience osteoporosis and arterial calcification.\nZinc: The Multifunctional Essential Mineral\nZinc, incorporated into FABRICAL MG K₂7 in highly bioavailable form, serves numerous critical physiological functions spanning immune competence, wound healing, protein synthesis, DNA synthesis, and cellular division. Regarding bone health specifically, zinc influences bone metabolism by supporting osteoblast activity and collagen synthesis, contributing to bone matrix formation and mineralization. Zinc also functions as a cofactor for alkaline phosphatase, an enzyme essential for bone mineralization.\nBeyond skeletal contributions, zinc supports immune system function, acting as a critical component of innumerable enzymes involved in immune cell development and function. Zinc deficiency impairs both innate and adaptive immunity, increasing susceptibility to infections. The mineral also supports sensory function (taste and smell), cognitive function, reproductive health, and skin integrity.\nMethylcobalamin: The Bioactive Vitamin B12\nMethylcobalamin represents the active, coenzyme form of vitamin B12, requiring no metabolic conversion to exert biological activity. This form demonstrates superior neurological benefits compared to cyanocobalamin, the synthetic form commonly used in supplements. Methylcobalamin directly participates in methionine synthesis and methylation reactions critical for nervous system health, DNA synthesis, red blood cell formation, and homocysteine metabolism.\nElevated homocysteine, resulting from inadequate B12 status, associates with increased cardiovascular disease risk, cognitive decline, and bone fragility. By supporting homocysteine conversion to methionine, methylcobalamin in FABRICAL MG K₂7 contributes to cardiovascular protection and potentially supports bone health through mechanisms independent of its well-established neurological and hematological roles.\nPrimary Uses and Clinical Applications of FABRICAL MG K₂7\nComprehensive Bone Health Support\nThe primary indication for FABRICAL MG K₂7 centers on comprehensive bone health support across various life stages and clinical scenarios. The formulation addresses all critical aspects of skeletal health: providing adequate calcium substrate for mineralization, ensuring calcium absorption through Vitamin D3, directing calcium into bone matrix via Vitamin K2-7, supporting bone matrix formation through magnesium and zinc, and protecting against homocysteine-related bone fragility through methylcobalamin.\nThis makes FABRICAL MG K₂7 particularly valuable for:\nOsteoporosis Prevention and Management: Postmenopausal women and elderly men experiencing age-related bone loss benefit from the formulation's comprehensive approach, potentially slowing bone density decline and reducing fracture risk.\nGrowing Children and Adolescents: During peak bone-building years, FABRICAL MG K₂7 supports optimal skeletal development, helping children and teenagers achieve maximum peak bone mass—a critical determinant of lifelong skeletal health.\nPregnancy and Lactation: Women during pregnancy and breastfeeding experience dramatically increased calcium demands. FABRICAL MG K₂7 helps prevent maternal bone density loss while supporting fetal skeletal development.\nCardiovascular Protection Through Proper Calcium Distribution\nThe Vitamin K2-7 component positions FABRICAL MG K₂7 as more than a bone health supplement—it's a cardiovascular protective formulation. By activating matrix Gla protein, the supplement helps prevent arterial calcification, potentially reducing cardiovascular disease risk. This dual benefit addresses the concerning observation that some individuals taking calcium supplements without adequate Vitamin K2 may experience increased cardiovascular events due to inappropriate calcium deposition in arterial walls.\nNeurological and Cognitive Support\nThe methylcobalamin component provides neurological support, particularly valuable for elderly individuals at risk for vitamin B12 deficiency due to reduced intrinsic factor production or those taking medications that impair B12 absorption (such as metformin or proton pump inhibitors). Adequate B12 status supports cognitive function, mood regulation, nerve conduction, and may help prevent peripheral neuropathy.\nImmune System Enhancement\nBoth zinc and vitamin D3 within FABRICAL MG K₂7 contribute significantly to immune competence. Vitamin D modulates both innate and adaptive immunity, while zinc supports immune cell development and function. This immune support proves particularly relevant during seasonal illness peaks or for individuals with compromised immunity.\nMuscle Function and Exercise Performance\nMagnesium's role in muscle contraction and relaxation, combined with calcium's involvement in excitation-contraction coupling, makes FABRICAL MG K₂7 valuable for athletes and physically active individuals. The formulation may help prevent exercise-associated muscle cramps, support recovery, and maintain electrolyte balance.\nKey Benefits of FABRICAL MG K₂7\nEnhanced Bioavailability and Absorption\nUnlike basic supplements using inferior ingredient forms, FABRICAL MG K₂7 utilizes premium, highly bioavailable compounds:\n\nCalcium Citrate Maleate offers superior absorption compared to calcium carbonate\nMagnesium Bisglycinate provides excellent absorption without gastrointestinal distress\nVitamin D3 is more potent than D2\nVitamin K2-7 (MK-7) has longer half-life and better tissue distribution than K1 or shorter-chain K2 forms\nMethylcobalamin is the active B12 form requiring no conversion\n\nThis superior bioavailability means lower doses can achieve therapeutic effects, reducing pill burden and potential adverse effects while maximizing benefits.\nSynergistic Nutrient Interactions\nFABRICAL MG K₂7's formulation recognizes that nutrients work together, not in isolation:\n\nVitamin D3 enhances calcium absorption while Vitamin K2-7 directs where that calcium goes\nMagnesium supports Vitamin D activation and calcium metabolism\nZinc supports bone matrix formation complementing calcium's role in mineralization\nMethylcobalamin supports methylation pathways that may influence bone health\n\nThis synergy delivers benefits exceeding what individual nutrients could provide separately.\nComprehensive Rather Than Fragmented Nutritional Support\nRather than requiring multiple separate supplements, FABRICAL MG K₂7 provides comprehensive support in a single, convenient formulation. This simplification improves compliance, reduces costs compared to purchasing individual supplements, and eliminates concerns about nutrient imbalances from uncoordinated supplementation.\nProtection Against the Calcium Paradox\nPerhaps the most significant benefit stems from the Vitamin K2-7 inclusion, which addresses the calcium paradox—simultaneously strengthening bones while protecting cardiovascular health by preventing arterial calcification. This represents a critical advancement over traditional calcium supplements that may inadvertently increase cardiovascular risk when taken without adequate Vitamin K2.\nSupport Across Multiple Physiological Systems\nBeyond bones, FABRICAL MG K₂7 benefits:\n\nCardiovascular System: Through arterial protection and homocysteine management\nNervous System: Via methylcobalamin's neurological support\nImmune System: Through vitamin D3 and zinc's immunomodulatory effects\nMuscular System: Via magnesium and calcium's roles in contraction\nMetabolic System: Through magnesium's involvement in glucose metabolism\n\nThis multi-system support delivers value far exceeding simple bone health supplementation.\nPotential Side Effects and Safety Considerations\nGenerally Well-Tolerated with Minimal Side Effects\nFABRICAL MG K₂7, when taken as directed, demonstrates excellent tolerability in most individuals. The selection of highly bioavailable, gentle nutrient forms specifically minimizes adverse effects common with inferior formulations.\nMild Gastrointestinal Effects\nSome users may initially experience mild digestive symptoms including:\n\nSlight nausea, particularly if taken on an empty stomach\nMinor bloating or gas\nMild constipation (though less likely than with calcium carbonate formulations)\n\nThese effects typically resolve within a few days as the body adjusts and can be minimized by taking the supplement with meals and ensuring adequate hydration.\nRare Allergic Reactions\nAlthough uncommon, some individuals may experience hypersensitivity to ingredients or excipients in the formulation. Signs include rash, itching, or swelling. Discontinuation and medical consultation are warranted if such reactions occur.\nConsiderations for Specific Populations\nIndividuals on Anticoagulants: Vitamin K2, while generally safer regarding coagulation than K1, may theoretically interact with warfarin. Patients on anticoagulation therapy should consult healthcare providers before starting FABRICAL MG K₂7, though recent evidence suggests K2 supplementation at consistent doses may not significantly affect INR stability.\nKidney Disease Patients: Individuals with chronic kidney disease should consult nephrologists before supplementing with calcium, magnesium, or vitamin D due to altered mineral metabolism and increased calcification risks in renal impairment.\nHypercalcemia Risk: Those with conditions predisposing to elevated calcium (hyperparathyroidism, sarcoidosis, certain cancers) should avoid supplementation without medical supervision.\nImportance of Appropriate Dosing\nExceeding recommended doses may increase adverse effect risks including:\n\nHypercalcemia (excessive calcium) causing nausea, constipation, kidney stones\nHypermagnesemia (excessive magnesium) causing diarrhea, cardiac abnormalities\nVitamin D toxicity (though requiring very high doses sustained over time)\n\nFollowing manufacturer's recommendations and consulting healthcare providers regarding individual needs ensures safe, effective use.\nRecommended Usage and Dosage Guidelines\nFABRICAL MG K₂7 should be taken according to manufacturer recommendations, typically one to two tablets daily with meals for optimal absorption of fat-soluble vitamins (D3 and K2-7). Taking the supplement with food containing some dietary fat further enhances absorption of these critical nutrients while minimizing potential gastrointestinal discomfort.\nConsistency in timing supports optimal benefits, as regular daily supplementation maintains stable nutrient levels. For individuals on multiple medications, spacing FABRICAL MG K₂7 administration at least two hours from certain medications (particularly thyroid hormones, bisphosphonates, or antibiotics) prevents potential absorption interference.\nIndividual requirements vary based on age, sex, dietary intake, health status, and specific deficiency risks. Healthcare provider consultation helps determine whether standard dosing suffices or whether adjustments are warranted. Periodic monitoring of vitamin D levels and other relevant biomarkers may be recommended to ensure supplementation achieves therapeutic goals without overshooting into excess.\nConclusion: FABRICAL MG K₂7 as a Comprehensive Nutritional Solution\nFABRICAL MG K₂7 stands as a sophisticated, scientifically formulated nutritional supplement that transcends traditional approaches to bone health support. By combining six synergistic nutrients in highly bioavailable forms, this innovative product addresses the complex, interconnected nature of skeletal health, cardiovascular protection, neurological function, and overall metabolic wellness.\nThe formulation's greatest strength lies in its comprehensive approach—recognizing that optimal health outcomes require balanced nutrition rather than isolated nutrient provision. The inclusion of Vitamin K2-7 particularly distinguishes FABRICAL MG K₂7 from conventional calcium supplements, addressing the critical calcium paradox and ensuring supplemented calcium strengthens bones while protecting cardiovascular structures.\nFor individuals seeking to support bone density, prevent osteoporosis, ensure adequate nutritional status during life stages of increased demand, or simply maintain optimal health through evidence-based supplementation, FABRICAL MG K₂7 offers a convenient, effective solution backed by nutritional science. Its excellent tolerability, superior ingredient quality, and multi-system benefits make it suitable for diverse populations from growing adolescents to active adults and elderly individuals concerned about age-related health challenges.\nAs with any nutritional supplement, FABRICAL MG K₂7 works best as part of a comprehensive health strategy including balanced nutrition, regular physical activity, adequate sleep, stress management, and appropriate medical care. It complements rather than replaces healthy lifestyle practices, providing nutritional insurance that helps fill gaps in modern diets while supporting long-term wellness.\nWhether you're proactively supporting your skeletal health, addressing identified nutritional deficiencies, or seeking comprehensive multi-nutrient support, FABRICAL MG K₂7 represents a premium choice that combines scientific sophistication with practical convenience, delivering measurable benefits that support vibrant health across all life stages.\n\nDisclaimer: This information is for educational purposes and does not constitute medical advice. Individual nutritional needs vary significantly based on numerous factors. Consult qualified healthcare professionals before starting any supplement regimen, particularly if you have existing health conditions, take medications, are pregnant or nursing, or have specific health concerns. Keep supplements out of reach of children and store according to manufacturer recommendations to maintain product integrity and safety.", "price": 250.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2274, "imageuri": "https://productimages.withfloats.com/actual/696621081f531945cbd90a0c.png", "tileimageuri": "https://productimages.withfloats.com/tile/696621081f531945cbd90a0c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-13T10:40:01.051Z", "updatedon": "2026-06-09T10:20:10.642Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fabrical-mg-k-7/2274", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FABRICAL MG K₂7", "category": "ORTHOLOGYRANG", "tags": [ "calcium citrate maleate magnesium bisglycinate tablets", "calcium citrate maleate with vitamin d3 k2 mk7", "magnesium bisglycinate with methylcobalamin tablets", "calcium citrate maleate vitamin k2-7 tablets", "best calcium citrate maleate tablets for bones", "magnesium bisglycinate tablets for muscle cramps", "methylcobalamin zinc tablets for nerve health", "calcium citrate maleate tablets for osteoporosis", "best calcium supplement with k2-7 for bone strength", "vitamin k2-7 mk7 with calcium benefits", "bone strength tablets with calcium magnesium zinc", "vitamin d3 k2 calcium tablets for elderly", "calcium citrate maleate tablets price in india", "best calcium magnesium vitamin d3 k2 tablets", "best bone health tablets with vitamin k2-7", "calcium magnesium zinc methylcobalamin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nicoumalone 2mg", "description": "NICOMALOM 2 \nNICOMALOM 2 features Nicoumalone, also known as Acenocoumarol, as its active ingredient in a 2mg tablet formulation. This medication belongs to the coumarin class of anticoagulants, which work by interfering with the liver's production of vitamin K-dependent clotting factors like II, VII, IX, and X. Unlike newer direct oral anticoagulants, NICOMALOM 2 offers a well-established profile with adjustable dosing based on individual INR monitoring, ideal for personalized treatment plans. Each tablet is crafted for easy oral administration, typically once daily, ensuring consistent blood thinning without the need for injections.\n​\n\nThe formulation ensures rapid absorption, with peak effects within hours, allowing for effective clot prevention in high-risk scenarios. Steris Healthcare emphasizes quality manufacturing standards, making NICOMALOM 2 suitable for adults managing chronic conditions or post-surgical recovery. Its compact packaging of 10 tablets per strip supports convenient storage and portability for ongoing therapy.\n​\n\nKey Uses\nNICOMALOM 2 excels in preventing and treating thromboembolic disorders where blood clots pose immediate dangers. Primary applications include deep vein thrombosis (DVT), where clots form in deep leg veins, and pulmonary embolism (PE), a potentially fatal blockage in lung arteries. Physicians also prescribe it to reduce stroke risk in patients with atrial fibrillation, a common irregular heartbeat that promotes clot formation in the heart.\n​\n\nBeyond these, NICOMALOM 2 prevents clots after surgeries like hip or knee replacements, or in those with mechanical heart valves. It supports prophylaxis in recurrent clotting episodes, ensuring smoother blood flow and oxygen delivery to vital organs. For patients in Jaipur and Rajasthan facing high incidences of cardiovascular issues due to lifestyle factors, this medication provides targeted protection tailored to regional healthcare needs.\n​\n\nMechanism of Action\nNICOMALOM 2 disrupts the clotting cascade by blocking vitamin K epoxide reductase, an enzyme essential for regenerating vitamin K. This inhibition halts the activation of prothrombin and other coagulation factors, thinning the blood and preventing new clot formation while allowing existing ones to dissolve naturally. The result is improved vascular patency, reducing symptoms like leg swelling in DVT or breathlessness in PE.\n​\n\nTherapeutic levels are maintained through regular INR testing, typically targeting 2.0-3.0 for most indications, which differentiates it from fixed-dose alternatives. This precise control minimizes over-anticoagulation risks, making it suitable for long-term use in diverse patient profiles, including the elderly under careful supervision.\n​\n\nKey Benefits\nPatients using NICOMALOM 2 experience significant reductions in clot-related hospitalizations, with studies showing up to 80% lower stroke incidence in atrial fibrillation cases. Its oral convenience enhances adherence compared to injectables, promoting better quality of life for those with mobility limitations post-surgery. Cost-effectiveness positions it as an accessible option in India's pharmaceutical market, especially for Steris Healthcare clients optimizing SEO-driven healthcare content.\n​\n\nAdditional advantages include reversibility with vitamin K administration in emergencies and compatibility with dietary adjustments for stable INR. For pharmaceutical marketers, NICOMALOM 2's established safety data supports strong branding in neurology and cardiology segments, driving patient trust and repeat prescriptions.\n​\n\nBenefit\tDescription\tClinical Impact \n​\nStroke Prevention\tLowers risk in atrial fibrillation by 60-70%\tFewer neurological emergencies\nPost-Surgical Protection\tReduces thromboembolism after orthopedic procedures\tShorter recovery times\nDVT/PE Management\tHalts clot progression effectively\tImproved mobility and oxygenation\nLong-Term Safety\tAdjustable dosing via INR monitoring\tSustained therapy without frequent switches\nAffordability\tCompetitive pricing in Indian market\tHigh accessibility for diverse demographics\nPotential Side Effects\nWhile effective, NICOMALOM 2 carries bleeding risks as its primary concern, including easy bruising, gum bleeding, or prolonged cuts. Common gastrointestinal issues like nausea, vomiting, or diarrhea affect some users, often manageable by taking with food. Less frequent effects encompass hair loss, skin rashes, or itching, which typically resolve with dose adjustments.\n​\n\nRare but serious reactions involve heavy menstrual bleeding, nosebleeds, or internal hemorrhage signaled by black stools or blood in urine—prompt medical attention is crucial. Elderly patients or those with liver/kidney impairment face heightened sensitivity, necessitating baseline assessments. Interactions with antibiotics, NSAIDs, or vitamin K-rich foods like spinach can amplify effects, underscoring the need for holistic patient education.\n​\nSide Effect Category\tExamples\tManagement Tips \n​\nCommon (Mild)\tBruising, nausea, diarrhea\tTake with meals; monitor diet\nSerious (Bleeding)\tNosebleeds, heavy periods, wounds\tSeek immediate care; INR checks\nRare\tHair loss, rash, appetite loss\tDose tweak; symptomatic relief\nDrug/Food Interactions\tWarfarin-like potentiators, greens\tInform doctor of all intake\nDosage and Safety Precautions\nStandard initial dosing starts at 2-4 mg daily, titrated per INR response, often 1-10mg maintenance. Children and the elderly require caution with lower starts. Avoid abrupt stops to prevent rebound clotting; inform surgeons/dentists pre-procedure. Pregnant or breastfeeding women should consult alternatives due to fetal risks.\n​\nRegular prothrombin time tests ensure efficacy, with lifestyle advice like avoiding contact sports minimizing injury. Store at room temperature, away from moisture.\n​\nConclusion\nNICOMALOM 2 delivers robust anticoagulation for clot prevention, balancing potent benefits against manageable risks through vigilant monitoring. For patients and healthcare providers in pharmaceutical hubs like Jaipur, it remains a cornerstone therapy, enhancing outcomes in DVT, PE, and beyond. Always prioritize professional guidance for optimal results.", "price": 227.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2026-03-13T05:57:23.788Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nicoumalone-2mg/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a92dd1542dd108c561935", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lacosamide 50mg", "description": "LACOSMILE 50 \nLacosamide 50mg\nLACOSMILE 50 is a high-quality formulation containing Lacosamide 50 mg, a widely prescribed antiepileptic medicine used for the effective management of seizure disorders. It plays a crucial role in controlling abnormal electrical activity in the brain, making it an essential medication for patients suffering from epilepsy. With its proven efficacy and safety profile, LACOSMILE 50 is trusted by healthcare professionals for both monotherapy and adjunctive therapy.\n\nThis medication is designed to provide consistent therapeutic results while ensuring patient comfort and improved quality of life.\n\nWhat is Lacosamide 50 mg?\n\nLacosamide is an anticonvulsant medicine that helps stabilize hyperexcitable neuronal membranes and inhibits repetitive neuronal firing. It selectively enhances the slow inactivation of voltage-gated sodium channels, which helps in reducing seizure frequency.\n\nLACOSMILE 50 is typically prescribed for patients diagnosed with partial-onset seizures, and it can be used alone or in combination with other antiepileptic drugs.\n\nHow Does LACOSMILE 50 Work?\n\nLACOSMILE 50 works by targeting the nervous system and regulating abnormal brain signals. In epilepsy, sudden bursts of electrical activity in the brain lead to seizures. Lacosamide helps by:\n\nSlowing down nerve signal transmission\nStabilizing overactive neurons\nPreventing the spread of seizure activity\n\nThis mechanism ensures better seizure control and reduces the chances of recurrent episodes.\n\nUses of LACOSMILE 50\n\nLACOSMILE 50 is widely used for the treatment and management of the following conditions:\n\n1. Partial-Onset Seizures\n\nIt is primarily used to control focal seizures in adults and adolescents.\n\n2. Epilepsy Management\n\nHelps reduce seizure frequency and severity, improving patient stability.\n\n3. Adjunctive Therapy\n\nUsed along with other antiepileptic medications when a single drug is not sufficient.\n\n4. Neurological Stability\n\nSupports overall brain function by maintaining balanced electrical activity.\n\nKey Benefits of LACOSMILE 50\n✔ Effective Seizure Control\n\nLACOSMILE 50 significantly reduces the frequency and intensity of seizures, allowing patients to lead a more stable life.\n\n✔ Well-Tolerated Medication\n\nCompared to many traditional antiepileptic drugs, Lacosamide has a favorable safety and tolerability profile.\n\n✔ Flexible Treatment Option\n\nCan be used alone or combined with other medications, depending on the patient’s condition.\n\n✔ Rapid Onset of Action\n\nBegins to show effectiveness within a short period when taken regularly as prescribed.\n\n✔ Improved Quality of Life\n\nBy reducing seizures, it helps patients maintain daily routines, work productivity, and social interactions.\n\n✔ Minimal Drug Interactions\n\nLacosamide has fewer interactions with other drugs, making it a safer choice for patients on multiple medications.\n\nDosage and Administration\nThe dosage of LACOSMILE 50 should always be taken as prescribed by a healthcare professional.\nIt is usually taken once or twice daily, with or without food.\nSwallow the tablet whole with water.\nDo not skip doses or stop the medication suddenly, as it may increase the risk of seizures.\nPossible Side Effects of LACOSMILE 50\n\nLike all medications, LACOSMILE 50 may cause some side effects. Most are mild and temporary, but some may require medical attention.\n\nCommon Side Effects\nDizziness\nHeadache\nNausea\nFatigue\nDouble vision\nSleepiness\nLess Common Side Effects\nCoordination problems\nMemory issues\nBlurred vision\nTremors\nSerious Side Effects (Seek Medical Help)\nIrregular heartbeat\nSevere allergic reactions\nMood changes or depression\nSuicidal thoughts\n\nPatients are advised to consult a doctor if any unusual symptoms persist or worsen.\n\nPrecautions and Warnings\n✔ Medical History\n\nInform your doctor if you have:\n\nHeart problems\nLiver or kidney disease\nHistory of depression or mental health issues\n✔ Pregnancy and Breastfeeding\n\nUse only if prescribed by a doctor. The benefits must outweigh potential risks.\n\n✔ Driving and Machinery\n\nLACOSMILE 50 may cause dizziness or drowsiness, so avoid driving or operating heavy machinery until you know how it affects you.\n\n✔ Alcohol Consumption\n\nAvoid alcohol, as it may increase side effects like dizziness and drowsiness.\n\nStorage Instructions\nStore in a cool, dry place away from sunlight\nKeep out of reach of children\nDo not use expired medication\nWhy Choose LACOSMILE 50?\n\nLACOSMILE 50 stands out due to its:\n\nReliable formulation quality\nConsistent therapeutic performance\nTrusted efficacy in seizure management\nPatient-friendly dosage strength\n\nIt is an ideal choice for healthcare providers looking for a dependable antiepileptic medication.\n\nConclusion\n\nLACOSMILE 50 (Lacosamide 50 mg) is a highly effective and well-tolerated medication designed for the management of epilepsy and partial-onset seizures. With its advanced mechanism of action, it helps stabilize brain activity and significantly reduces seizure frequency.\n", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "AEDs", "food", "brain", "EMAIL", "lives", "water", "impact", "tablet", "epilepsy", "response", "disorder", "patients", "severity", "Benefits", "frequency", "LACOSMILE", "two doses", "treatment", "condition", "management", "same times", "occurrence", "combination", "information", "individuals", "bloodstream", "sterispharma", "tolerability", "sterisonline", "Introduction", "full control", "exact dosage", "Key Features", "CALL/WHATSAPP", "Administration", "Initial Dosage", "overall quality", "Improved Quality", "200 mg to 400 mg", "seizure activity", "daily activities", "Lacosamide 50 mg", "single medication", "slow inactivation", "Maintenance Dosage", "Neurostabilization", "Adjunctive Therapy", "healthcare provider", "electrical activity", "typical starting dose", "partial-onset seizures", "usual maintenance dose", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1840, "imageuri": "https://productimages.withfloats.com/actual/666a92e0475de163fe8f70bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a92e0475de163fe8f70bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:34:05.541Z", "updatedon": "2026-03-30T08:13:27.321Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lacosamide-50mg/1840", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 50 ", "category": "NEUROLOGYRANGE", "tags": [ "lacosamide 50 mg uses", "Lacosamide (50mg)", "lacosamide 50 mg price", "lacosamide 50 mg side effects", "lacosam 50 substitute", "lacosamide 50 mg tablet uses in hindi", "lacosamide 50 mg uses for epilepsy", "lacosamide 50 mg dosage and side effects", "lacosamide tablet 50 mg for seizure control", "lacosamide 50 mg tablet price in India", "lacosamide tablets 50 mg wholesale price", "lacosamide 50 mg B2B supplier India", "what is lacosamide 50 mg used for in epilepsy patients", "is lacosamide 50 mg safe for seizures treatment", "how long does lacosamide 50 mg take to work" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a8fe21542dd108c561889", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lacosamide 50mg", "description": "Introduction\n\nEpilepsy is a chronic neurological disorder characterized by recurrent seizures caused by abnormal electrical activity in the brain. It affects millions of people worldwide and can significantly impact daily life, safety, and mental well-being. Effective seizure control is essential to improve quality of life and reduce complications associated with uncontrolled epilepsy.\n\nLacosamide 50 mg is an antiepileptic medication (AED) widely used for the management of partial-onset seizures in adults and, in some cases, adolescents. It is known for its novel mechanism of action and is often used as an adjunct therapy when seizures are not fully controlled by other medications.\n\nThis medicine helps stabilize neuronal activity in the brain and reduces the frequency and intensity of seizures. Due to its predictable pharmacokinetics and good tolerability profile, Lacosamide has become an important part of modern epilepsy treatment protocols.\n\nWhat Is Lacosamide 50 mg?\n\nLacosamide is an anticonvulsant medication used to treat epilepsy. It belongs to a class of drugs that work by stabilizing hyperexcitable nerve cells in the brain.\n\nLacosamide 50 mg is commonly prescribed as a starting or maintenance dose in patients requiring gradual titration to achieve optimal seizure control.\n\nIt is typically used in combination with other antiepileptic drugs or as monotherapy depending on the patient's condition and physician recommendation.\n\nHow Lacosamide 50 mg Works\n\nLacosamide works by targeting specific sodium channels in the brain that are responsible for neuronal firing.\n\nMechanism of Action of Lacosamide\n\nLacosamide enhances the slow inactivation of voltage-gated sodium channels. This action helps:\n\nStabilize overactive neurons\nReduce abnormal electrical discharges\nPrevent seizure spread in the brain\n\nUnlike traditional antiepileptic drugs that block sodium channels broadly, Lacosamide selectively modulates neuronal excitability, which contributes to its improved safety and tolerability profile.\n\nUses of Lacosamide 50 mg\n\nLacosamide 50 mg is primarily used for:\n\n1. Partial-Onset Seizures\n\nIt is indicated for the treatment of partial-onset seizures in adults with epilepsy, either as monotherapy or adjunct therapy.\n\n2. Adjunct Therapy in Epilepsy\n\nLacosamide is often added to existing treatment regimens when seizure control is inadequate with single-drug therapy.\n\n3. Epileptic Disorder Management\n\nIt helps reduce seizure frequency and severity in patients with long-term epilepsy.\n\n4. Neurological Stabilization\n\nIt supports overall neuronal stability and reduces abnormal brain activity.\n\nKey Benefits of Lacosamide 50 mg\n1. Effective Seizure Control\n\nLacosamide helps reduce the frequency and intensity of partial-onset seizures, improving daily functioning and safety.\n\n2. Novel Mechanism of Action\n\nIts unique action on slow sodium channel inactivation makes it different from many traditional antiepileptic drugs.\n\n3. Better Tolerability Profile\n\nMany patients tolerate Lacosamide well compared to older anticonvulsants, with fewer cognitive side effects.\n\n4. Flexible Use in Combination Therapy\n\nIt can be safely combined with other antiepileptic medications under medical supervision.\n\n5. Improved Quality of Life\n\nBy reducing seizure episodes, patients often experience improved independence, confidence, and mental well-being.\n\n6. Predictable Pharmacokinetics\n\nLacosamide has stable absorption and consistent plasma levels, which supports reliable therapeutic effects.\n\n7. Suitable for Long-Term Therapy\n\nIt is often used as part of long-term epilepsy management plans.\n\nClinical Importance of Lacosamide 50 mg\n\nLacosamide has been studied in multiple clinical trials and has demonstrated:\n\nSignificant reduction in seizure frequency\nImproved responder rates in partial epilepsy\nGood safety profile in long-term use\nEffective adjunct therapy outcomes\n\nIts role in epilepsy management continues to expand as more evidence supports its efficacy and tolerability.\n\nDosage Guidelines for Lacosamide 50 mg\n\nDosage is strictly individualized and must be prescribed by a neurologist.\n\nGeneral Guidelines:\nInitial dose often starts low (e.g., 50 mg twice daily in many cases)\nGradual titration based on patient response\nMaintenance dose varies depending on clinical outcome\nImportant Notes:\nDo not stop medication suddenly\nRegular monitoring may be required\nDose adjustments may be needed in kidney or liver impairment\nSide Effects of Lacosamide 50 mg\n\nLike all medications, Lacosamide may cause side effects in some individuals.\n\nCommon Side Effects\nDizziness\nHeadache\nNausea\nDouble vision\nFatigue\nSleepiness\n\nThese effects are usually mild and may decrease as the body adjusts.\n\nSerious Side Effects of Lacosamide 50 mg\n\nAlthough rare, serious side effects may include:\n\nIrregular heartbeat (PR interval prolongation)\nSevere dizziness or fainting\nAllergic reactions (rash, swelling)\nMood changes or depression\nSuicidal thoughts (rare but important warning)\n\nImmediate medical attention is required if any serious symptoms occur.\n\nPrecautions & Warnings\nHeart Conditions\n\nPatients with heart rhythm disorders should use Lacosamide with caution.\n\nKidney or Liver Disease\n\nDose adjustment may be required in impaired organ function.\n\nPregnancy & Breastfeeding\n\nUse only if clearly prescribed by a healthcare professional.\n\nDriving & Machinery\n\nLacosamide may cause dizziness or drowsiness; avoid driving if affected.\n\nAlcohol Use\n\nAlcohol may increase side effects such as drowsiness and dizziness.\n\nDrug Interactions\n\nLacosamide may interact with:\n\nOther antiepileptic drugs\nMedications affecting heart rhythm\nCNS depressants (sleeping pills, sedatives)\nAlcohol\n\nAlways inform your doctor about all medications being taken.\n\nWho Should Use Lacosamide 50 mg?\n\nLacosamide 50 mg is suitable for:\n\nAdults diagnosed with partial-onset seizures\nPatients requiring adjunct epilepsy therapy\nIndividuals not responding adequately to first-line AEDs\nPatients under neurologist supervision for long-term seizure control\nHow to Take Lacosamide 50 mg\nTake exactly as prescribed by your doctor\nCan be taken with or without food\nTake at the same time daily for best results\nSwallow with water, do not crush or chew\n\nConsistency is important for effective seizure control.\n\nExpected Results\nShort-Term\nStabilization of seizure activity may begin within weeks\nLong-Term\nReduced seizure frequency\nImproved neurological stability\nBetter daily functioning and independence\n\nResults vary depending on individual response and adherence.\n\nFrequently Asked Questions \n\nWhat is Lacosamide 50 mg used for?\nIt is used to treat partial-onset seizures in epilepsy patients.\n\nDoes Lacosamide cure epilepsy?\n\nNo, it helps control seizures but does not cure epilepsy.\n\nHow long does it take to work?\n\nImprovement may be seen within a few weeks, but full benefit may take longer.\n\nCan Lacosamide be taken alone?\n\nYes, in some cases it is used as monotherapy or combined with other AEDs.\n\nIs Lacosamide safe for long-term use?\n\nYes, under medical supervision it is commonly used for long-term seizure management.\n\nWhat should I do if I miss a dose?\n\nTake it as soon as you remember, but do not double the next dose.\n\nConclusion\n\nLacosamide 50 mg is an effective and modern antiepileptic medication designed to help manage partial-onset seizures and improve neurological stability. With its unique mechanism of action targeting slow sodium channel inactivation, it offers reliable seizure control with a generally favorable safety profile.\n\nWhen used under proper medical supervision, Lacosamide helps patients achieve better seizure management, improved quality of life, and greater independence in daily activities. However, it is important to follow prescribed dosage instructions, attend regular check-ups, and avoid abrupt discontinuation to ensure safe and effective therapy.", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "AEDs", "life", "food", "lives", "water", "brain", "EMAIL", "tablet", "impact", "100 mg", "150 mg", "patients", "response", "disorder", "epilepsy", "severity", "Benefits", "frequency", "LACOSMILE", "two doses", "condition", "treatment", "management", "same times", "occurrence", "Lacosamide", "individuals", "combination", "information", "bloodstream", "sterispharma", "tolerability", "Introduction", "sterisonline", "Key Features", "exact dosage", "full control", "CALL/WHATSAPP", "Administration", "Initial Dosage", "overall quality", "Improved Quality", "200 mg to 400 mg", "seizure activity", "daily activities", "slow inactivation", "single medication", "Neurostabilization", "Adjunctive Therapy", "Maintenance Dosage", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "partial-onset seizures", "antiepileptic medication", "other antiepileptic drugs", "additional seizure control", "consistent medication levels", "voltage-gated sodium channels", "hyperexcitable neuronal membranes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1838, "imageuri": "https://productimages.withfloats.com/actual/666a8fe5117f82c50b0ab68e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666a8fe5117f82c50b0ab68e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T06:21:22.539Z", "updatedon": "2026-06-09T12:35:04.114Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lacosamide-50mg/1838", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LACOSMILE 150 ", "category": "NEUROLOGYRANGE", "tags": [ "lacosmile 150 mg side effects", "lacosamide mechanism of action", "Lacosamide 150 mg", "lacosamide 150 mg price", "lacosam 150 uses", "lacosamide 50mg", "tablet lacosamide 50mg", "lacosamide 50mg uses", "tab lacosamide 50mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e74687f0960e14a2d95a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gefitinib 250mg", "description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n", "price": 2760.0, "discountamount": 828.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "Call", "Uses", "Rash", "Note", "NSCLC", "Email", "nausea", "Dosage", "spread", "WhatsApp", "diarrhea", "Gefitinib", "treatment", "One tablet", "GEFISTERIS", "information", "sterispharma", "consultation", "sterisonline", "Side Effects", "cancer cells", "targeted therapy", "Regular monitoring", "healthcare provider", "small cell lung cancer", "healthcare professional", "specific EGFR mutations", "epidermal growth factor receptor", "potential liver function alterations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1530, "imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:56:06.808Z", "updatedon": "2026-04-15T10:04:00.767Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GEFISTERIS 250", "category": "Oncology", "tags": [ "gefitinib 250 mg uses", "gefitinib 250 mg online purchase", "gefitinib 250 mg tablets price in india", "non-small cell lung cancer (NSCLC).", "triggered by chemotherapy.", "cancer biology.", "Superior Efficacy in EGFR-Mutant NSCLC", "gefitinib 250mg", "gefitinib 250mg tablet", "gefitinib 250mg tab", "gefitinib 250 mg tablet uses in lung cancer", "gefitinib tablets 250 mg dosage and benefits", "gefitinib 250 mg price in india", "gefitinib 250 mg EGFR inhibitor for NSCLC treatment india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662d50f8ecffe165c355141", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "capecitabine 500mg", "description": "CAPECITIME 500 \nCapecitabine lp 500mg\nCAPECITIME 500 represents a significant advancement in the landscape of oncological therapeutics. Manufactured with stringent quality standards by Steris Healthcare, this pharmaceutical product contains Capecitabine IP 500mg, a potent antimetabolite chemotherapy agent. It is designed to offer a balance of high efficacy and patient convenience, shifting the paradigm of cancer care from exclusively hospital-based intravenous treatments to a manageable, home-based oral regimen.\n\nIn the complex battle against malignancy, precision and tolerability are paramount. CAPECITABINE 500 serves as a 'prodrug'—a medication that remains largely inactive until it enters the body. Once ingested, it undergoes a unique three-step enzymatic conversion process, transforming into its active cytotoxic form, 5-fluorouracil (5-FU), preferentially within tumor tissues. This mechanism aims to maximize the destruction of cancer cells while striving to spare healthy tissues, making CAPECITABINE 500 a cornerstone therapy for patients battling colorectal, breast, and gastric cancers.\n\nMechanism of Action: The Science of CAPECITABINE 500\nUnderstanding how CAPECITIME 500 works is essential to appreciating its value. Unlike traditional chemotherapy that attacks all rapidly dividing cells indiscriminately, capecitabine is designed to be smarter.\n\nAbsorption and Conversion: Upon swallowing the CAPECITIME 500 tablet, the drug is absorbed through the intestinal wall. It passes through the liver, where it is converted into an intermediate compound.\n\nTumor Targeting: The final conversion to the active cancer-killing agent, 5-FU, occurs primarily in the presence of an enzyme called thymidine phosphorylase. Research indicates that this enzyme is often found in higher concentrations in tumor tissues compared to normal healthy tissues.\n\nDNA Disruption: Once active inside the cancer cell, the drug mimics essential nutrients the cell needs to grow (specifically inhibiting thymidylate synthase). This effectively 'starves' the cancer cell of the building blocks required for DNA replication and repair, leading to cell death (apoptosis) and slowing tumor progression.\n\nTherapeutic Indications and Uses\nCAPECITABINE 500 is a versatile oncology medication prescribed by specialists for several specific types of cancer. Its efficacy is well-documented in various clinical settings:\n\n1. Colorectal Cancer\nAdjuvant Treatment: CAPECITIME 500 is widely used for patients with Stage III (Dukes' C) colon cancer who have undergone surgery to remove the primary tumor. In this setting, the drug acts as a 'cleanup' agent, targeting any microscopic cancer cells that may remain, significantly reducing the risk of recurrence and improving survival rates.\n\nMetastatic Colorectal Cancer: For cases where the cancer has spread (metastasized) to other parts of the body, CAPECITIME 500 is often the first-line treatment. It can be used as a standalone therapy (monotherapy) or in combination with other chemotherapy agents to control disease progression.\n\n2. Breast Cancer\nAdvanced or Metastatic Disease: CAPECITIME 500 plays a critical role in treating advanced breast cancer. It is frequently prescribed when the cancer has stopped responding to other standard chemotherapy treatments, such as paclitaxel or anthracyclines.\n\nCombination Therapy: It is often paired with other drugs (e.g., docetaxel) to enhance the attack on cancer cells, providing a synergistic effect that can shrink tumors more effectively than single agents alone.\n\n3. Gastric (Stomach) Cancer\nCAPECITABINE 500 is also a key component in the treatment regimen for advanced gastric cancer, often used in combination with platinum-based chemotherapy. It helps in palliative care settings to extend survival and improve the quality of life for patients with inoperable tumors.\n\nKey Benefits of CAPECITIME 500\nPatients and healthcare providers choose CAPECITABINE 500 for several distinct advantages that set it apart from conventional intravenous chemotherapy.\n\n1. Convenience of Oral Administration\nPerhaps the most immediate benefit for the patient is the form factor. Traditional 5-FU treatment requires continuous intravenous (IV) infusion, necessitating frequent hospital visits, catheter lines, or portable pumps. CAPECITIME 500 is a tablet. This allows patients to take their medication in the comfort of their own homes, reducing hospital visits and allowing them to maintain a more normal daily routine, work schedule, and family life.\n\n2. Targeted 'Tumor-Activated' Therapy\nBecause the drug is converted to its active form largely within the tumor site (due to higher enzyme levels there), CAPECITIME 500 achieves high concentrations of medicine exactly where it is needed—inside the cancer. This targeted approach aims to reduce systemic toxicity compared to older chemotherapy methods that flood the entire bloodstream with active toxins.\n\n3. Proven Efficacy & Quality\nManufactured by Steris Healthcare, CAPECITIME 500 adheres to WHO-GMP (Good Manufacturing Practices) standards, ensuring that patients receive a product of high purity, stability, and consistent dosage. Clinical data supports that oral Capecitabine is at least equivalent to intravenous 5-FU in terms of survival outcomes for colorectal cancer, with the added benefit of improved convenience.\n\n4. Flexible Combination Partner\nCAPECITIME 500 is highly versatile. It can be effectively combined with a wide range of other cancer therapies, including radiation therapy and biologic agents, allowing oncologists to tailor treatment plans to the specific genetic makeup and stage of the patient's cancer.\n\nPotential Side Effects and Management\nWhile CAPECITIME 500 is designed to be more targeted, it is still a potent chemotherapy drug, and side effects can occur. Being aware of these helps patients manage them effectively.\n\nCommon Side Effects\nGastrointestinal Issues: Diarrhea, nausea, vomiting, and abdominal pain are common. These are usually manageable with dietary changes and additional medications prescribed by the doctor.\n\nFatigue: A general sense of tiredness or weakness is frequently reported.\n\nHand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): This is a specific side effect where the palms of the hands and soles of the feet become red, swollen, tender, or peeled. It is caused by small amounts of the drug leaking from capillaries in these areas.\n\nSerious Side Effects (Rare but Important)\nCardiac Symptoms: Rarely, patients may experience chest pain or heart palpitations.\n\nLow Blood Cell Counts: The drug can temporarily lower the number of white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bruising).\n\nSevere Diarrhea: If left untreated, this can lead to dehydration.\n\nManaging Side Effects\nHydration: Patients are advised to drink plenty of fluids.\n\nSkin Care: For Hand-Foot Syndrome, keeping hands and feet moisturized, avoiding tight shoes, and staying away from hot water/heat sources is recommended.\n\nCommunication: Early reporting of side effects to a healthcare provider often allows for dose adjustments that can stop the side effects from becoming severe.\n\nDosage and Administration\nPrescription Only: CAPECITABINE 500 is a prescription-only medicine and must be taken exactly as directed by an oncologist.\n\nTypical Cycle: A common regimen involves taking the tablets twice daily (morning and evening) for 14 consecutive days, followed by a 7-day rest period. This constitutes one 21-day cycle.\n\nWith Food: It is crucial to take CAPECITIME 500 within 30 minutes after a meal with water. Taking it with food reduces the risk of stomach upset and ensures proper absorption.\n\nConclusion\nCAPECITIME 500 (Capecitabine 500mg) stands as a vital therapeutic option in modern oncology. By combining the potency of traditional chemotherapy with the smart science of tumor-enzyme activation, it offers a powerful weapon against colorectal, breast, and gastric cancers.\n\nBeyond its chemical efficacy, CAPECITIME 500 offers the profound benefit of dignity and independence. The ability to self-administer chemotherapy at home empowers patients, reducing the burden of clinical visits and allowing them to focus more on healing and living. With its high-quality formulation by Steris Healthcare, CAPECITIME 500 provides a reliable, effective, and patient-centric solution for cancer management.", "price": 1222.0, "discountamount": 366.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "blood", "Email", "class", "amount", "nausea", "doctor", "disorder", "WhatsApp", "headache", "CABERGLOW", "dizziness", "conditions", "CAPECITIME", "medication", "infertility", "information", "Capecitabine", "constipation", "instructions", "sterispharma", "sterisonline", "Cabergoline IP", "unusual symptoms", "hyperprolactinemia", "associated symptoms", "Excessive prolactin", "Common side effects", "other related issues", "normal hormone levels", "healthcare professional", "excess prolactin hormone", "dopamine receptor agonists", "irregular menstrual periods" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1525, "imageuri": "https://productimages.withfloats.com/actual/667d2be5cd6f42ac046088e1.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2be5cd6f42ac046088e1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T09:38:23.283Z", "updatedon": "2026-03-17T07:22:43.148Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//capecitabine-500mg/1525", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CAPECITIME 500 ", "category": "NEPHROLOGYRANGE", "tags": [ "capecitabine 500 mg tablet price", "capecitabine 500 mg tablet dosage", "capecitabine 500 mg tablet side effects", "CAPECITIME 500", "Capecitabine IP 500mg", "Combination Therapy", "CAPECITIME 500 is a tablet.", "colorectal, breast, and gastric cancers.", "CAPECITIME 500", "5-FU in terms of survival outcomes for colorectal cancer.", "capecitabine 500mg oral chemotherapy tablets", "capecitabine 500mg chemotherapy at home", "capecitabine 500mg for metastatic breast cancer", "buy capecitabine 500mg online", "capecitabine 500mg price per tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }